Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (271-280 of 651) with videos related to

Pageof 66
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2013
Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis modelsMohamed A Chinnaratha, Gary P Jeffrey, Gerry MacQuillan, et al.
Journal of Molecular Histology|July 31, 2009
Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus diseaseGerry C MacQuillan, Paul Caterina, Bastiaan de Boer, et al.
Digestive Diseases and Sciences|May 30, 2018
The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment VariableMichael C Wallace, Matthew Knuiman, Yi Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 26, 2018
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver diseaseLuis C Bertot, Gary P Jeffrey, Bastiaan de Boer, et al.
Neuropharmacology|May 4, 2023
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disordersFerdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, et al.
Journal of Clinical Medicine|October 29, 2020
Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyTimothy M E Davis, Kirsten E Peters, S A Paul Chubb, et al.
Internal Medicine Journal|October 20, 2015
The association between chronic hepatitis C infection and cardiovascular riskP Pateria, G P Jeffrey, G MacQuillan, et al.
The Medical Journal of Australia|November 5, 1997
Liver transplantation in Western Australia: improved services to an isolated populationD G Ormonde, G P Jeffrey, R Bell, et al.
Journal of Medicinal Chemistry|May 19, 2009
Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonistsSantosh S Kulkarni, Mu-Fa Zou, Jianjing Cao, et al.
Journal of Medical Imaging and Radiation Oncology|January 11, 2017
Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western AustraliaPuraskar Pateria, Gary P Jeffrey, George Garas, et al.
Pageof 66

Showing results (271-280 of 651) with videos related to

Sort By:
Pageof 66
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2013
Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis modelsMohamed A Chinnaratha, Gary P Jeffrey, Gerry MacQuillan, et al.
Journal of Molecular Histology|July 31, 2009
Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus diseaseGerry C MacQuillan, Paul Caterina, Bastiaan de Boer, et al.
Digestive Diseases and Sciences|May 30, 2018
The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment VariableMichael C Wallace, Matthew Knuiman, Yi Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 26, 2018
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver diseaseLuis C Bertot, Gary P Jeffrey, Bastiaan de Boer, et al.
Neuropharmacology|May 4, 2023
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disordersFerdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, et al.
Journal of Clinical Medicine|October 29, 2020
Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyTimothy M E Davis, Kirsten E Peters, S A Paul Chubb, et al.
Internal Medicine Journal|October 20, 2015
The association between chronic hepatitis C infection and cardiovascular riskP Pateria, G P Jeffrey, G MacQuillan, et al.
The Medical Journal of Australia|November 5, 1997
Liver transplantation in Western Australia: improved services to an isolated populationD G Ormonde, G P Jeffrey, R Bell, et al.
Journal of Medicinal Chemistry|May 19, 2009
Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonistsSantosh S Kulkarni, Mu-Fa Zou, Jianjing Cao, et al.
Journal of Medical Imaging and Radiation Oncology|January 11, 2017
Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western AustraliaPuraskar Pateria, Gary P Jeffrey, George Garas, et al.
Pageof 66